Fact Based List:

Kaiser Health News: Marathon's Emflaza - 5 Reasons Why An $89,000 Drug Has Congress Fuming

  1. It’s not a new drug
  2. It’s not a scientific breakthrough
  3. Emflaza doesn’t work alone
  4. Marathon has cultivated relationships in the Duchenne patient community
  5. Timing is everything

Source: Kaiser Health News, Feb 16, 2017
Source URL: http://khn.org/news/5-reasons-why-an-89k-drug-has-congress-f...